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Despite dramatic decreases in the incidence of healthcare-
associated infections (HAIs) in recent years, a large prevalence
study of US acute-care hospitals estimated that ~722,000 HAIs
occurred in 2011, resulting in ~75,000 deaths.1 Several
decades ago, Weinstein2 theorized that pathogens causing HAIs
in the intensive care unit (ICU) had several sources: the patients’
endogenous flora (40%–60%), cross-infection via the hands of
healthcare personnel (HCP; 20%–40%), antibiotic-driven
changes in flora (20%–25%), and other causes (including
contamination of the environment; 20%).2 More recently,
accumulating scientific evidence has indicated that contamina-
tion of environmental surfaces in hospital rooms plays an
important role in the transmission of several key healthcare-
associated pathogens, including methicillin-resistant Staphylo-
coccus aureus (MRSA), vancomycin-resistant Enterococcus spp
(VRE), Clostridium difficile, Acinetobacter spp, and norovirus.3–6
In general, all of these pathogens share the following character-
istics: ability to survive for prolonged periods of time on envir-
onmental surfaces, ability to remain virulent after environmental
exposure, frequent contamination of the hospital environment,
ability to colonize patients, ability to contaminate or transiently
colonize the hands of HCP, and transmission via the con-
taminated hands of HCP.3–6 Evidence supporting the role of
contaminated surfaces in the transmission of key healthcare-
associated pathogens includes the following observations. (1)
The surfaces in rooms of colonized or infected patients are
frequently contaminated with the pathogen.3–6 (2) Contact with
hospital-room surfaces ormedical equipment byHCP frequently
leads to contamination of hands and/or gloves.6 (3) The patient
admitted to a room previously occupied by a patient colonized or
infected with a pathogen (eg, MRSA, VRE, C. difficile,
Acinetobacter) has a substantially increased likelihood (ie, 39%–
353%) of developing colonization or infection with that patho-
gen.6 (4) Improved terminal cleaning of rooms decreases
environmental pathogens7 and the rate of individual patient
colonization and/or infections; it also leads to a decreased
facility-wide rate of colonization and/or infection.8
Unfortunately, inadequate terminal room disinfection is
common.7 In fact, studies have demonstrated that <50% of
room surfaces are cleaned.7 Therefore, and not surprisingly,
many room surfaces remain contaminated with a multidrug-
resistant organisms (MDROs) following terminal room
disinfection.5,6 Although enhanced education of environ-
mental service staff with feedback regarding cleaning
effectiveness (eg, fluorescent dye) improves cleaning effec-
tiveness, overall cleaning remains suboptimal.7 For this reason,
“no-touch” methods of terminal room disinfection have been
developed.9–14 No-touch methods that use ultraviolet (UV)
light devices or hydrogen peroxide systems for terminal room
disinfection when the occupant has been colonized or infected
with a MDRO have been demonstrated to reduce the risk of
the subsequent room occupant developing colonization and/
or an HAI.11,13 Importantly, some studies have demonstrated a
facility-wide reduction of HAIs15,16; furthermore, these
reductions were not related to improved hand hygiene or to
environmental cleaning compliance.17,18
One of the limitations of currently available UV devices or
hydrogen peroxide systems is that they can only be used for
terminal disinfection because patients and HCP must evacuate
the room prior to use. Because daily room disinfection has
been shown to reduce contamination of HCP hands and
gloves,19 there has been interest in developing “no-touch”
methods for decreasing MDRO surface contamination on a
continuous basis.9 Such methods have been reviewed and
include self-disinfecting surfaces using heavy metals, light-
activated photosensitizers, high-intensity narrow-spectrum
light, low-dose continuous hydrogen peroxide, photocatalytic
disinfection, bacteriophage-modified surfaces, and altered
surface topography.12,14,20–22 Of these potential methods, the
best studied is the use of heavy metals (eg, silver, copper) with
copper-coated or impregnated surfaces; it is the only method
that has been assessed in clinical trials.20–22
The studies assessing the effectiveness of no-touch methods
including self-disinfecting surfaces for disinfection of room
surfaces in hospitals can be divided into 3 general approaches.
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(1) the effectiveness of the self-disinfecting surface to kill or
inhibit microbes artificially placed on the self-disinfecting
surface, (2) the level of contamination on self-disinfecting
surfaces in actual patient rooms compared to a “control”
surface and (3) most importantly, clinical trials of a
self-disinfecting surface to reduce HAIs.
Copper is an essential trace element in most living organ-
isms, and >30 types of copper-containing proteins have been
described.20 The use of copper by humans dates back to the
fifth and sixth millennia BC.23 Ancient civilizations used copper
or copper compounds to prevent the growth of barnacles on
the hulls of ships and as a medicinal agent.20 In the 19th and
20th centuries, inorganic copper preparations were used to
treat chronic adenitis, eczema, impetigo, tuberculous infec-
tions, and syphilis.23 The cause of bacterial cell death to
exposure to copper may relate to its ability to accept and
donate single electrons leading to the generation of reactive
oxygen species, resulting is cell lysis.14,20,21,23 In healthcare
facilities, the most well-studied use of copper has been as a
“self-disinfecting” surface, but many other uses have been
studied, including copper-containing paints, fabrics, hand
rubs, microfiber cleaning cloths, pens, and fins within
air-conditioning units.20
Multiple studies have assessed the contact killing of
microbes by copper surfaces.23 Contact with copper has been
demonstrated to kill a variety of healthcare-associated patho-
gens including Staphylococcus aureus (including methicillin-
resistant S. aureus), Enterococcus spp, Escherichia coli, Klebsiella
pneumoniae, Acinetobacter baumannii, Pseudomonas aerugi-
nosa, and Mycobacterium tuberculosis.20 In general, contact
killing of vegetative bacteria and fungi occurs rapidly with
>6-log10 inactivation per hour. Spores (eg, C. difficile) are
inactivated more slowly, but >3-log10 are inactivated within
24 hours.23,24
In this issue of Infection Control and Hospital Epidemiology,
Souli et al25 report on the frequency and level of contamina-
tion of multiple copper-coated surfaces (ie, patient beds, side
table, IV pole, side cart handles, and manual antiseptic
dispenser) compared to control surfaces in a patient room in
an intensive care unit.25 The study was performed in a Greek
ICU setting in which evidence showed that the environment
was considerably more contaminated than other settings and
where highly resistant organisms predominated. For example,
62% of K. pneumoniae isolated from the environment were
resistant to carbapenems and 100% were multidrug resistant;
similarly, 98% of A. baumannii were resistant to carbapenems
and 99% were multidrug resistant. Their study was conducted
in 2 phases: In phase 1, enhanced environmental sampling was
performed to identify the most microbiologically con-
taminated items to ‘copperize’; this targeted use of copper
items is an important strength of the study. Phase 2 was the
intervention phase; in phase 2a, copper-coated objects were
placed next to uncoated objects (controls); and in phase 2b,
cooper-coated objects were all placed in a single ICU com-
partment and non–copper-coated objects were placed in a
different ICU compartment (controls). Combining the data
for phases 2a and 2b revealed that copper-coated surfaces were
less likely to be microbially contaminated (ie, 55.6% vs 72.5%
for controls, P< .0001). Copper-coated surfaces were sig-
nificantly less likely to be contaminated with gram-negative
bacilli or Enterococcus spp, but no statistical reduction for
A. baumannii, K. pneumoniae, or S. aureus was observed.
Overall, the level of contamination was reduced by ~0.7-log10
(P= .049). Importantly, no significant reduction was observed
in phase 2a, in which copper items were placed next to
uncoated objects, suggesting a possible interaction between
the number of copper items and the level of reduction, which
requires further investigation. The statistical approach used
did not take into account the full range of variables; most
importantly, indicators of hand-hygiene compliance and
patient-level variables could have been included in a model
with copper items as a separate variable. Souli et al reported no
difference in hand-hygiene compliance during the study, but
the effectiveness of environmental clean/disinfection was not
assessed. Other limitations include the use of alcohol spray for
daily disinfection of surfaces, which is an unusual approach
and may limit the generalizability of the study; lack of rando-
mization of patients to beds with copper items; and the lack of
clinical and cost-effectiveness outcomes.
Multiple studies of copper-coated surfaces or devices have
been conducted in the healthcare setting comparing the level
and frequency of surface contamination to control surfaces
(for a review of studies, see Weber and Rutala,20 Humphreys,21
Muller et al,22 Weaver et al,24 and O’Gorman and Hum-
phreys26). Studies have either used concurrent non–copper-
coated control surfaces or a crossover design. Muller et al22
reported that 5 of 7 copper studies of copper-coated surfaces
or fabrics reviewed demonstrated a significant reduction
in quantitative bacterial contamination of <1-log10 (range,
<1-log10 to 2-log10). Limitations of the studies noted byMuller
et al22 included lack of blinding, lack of randomization, and
in general, failure to measure potential confounding factors
(eg, hand hygiene compliance, effectiveness of cleaning by
environmental services) or reported any patient-level data.
Similar to previous studies, 2 more recent studies also
demonstrated significant reductions of microbial contamina-
tion on copper-coated surfaces compared to control surfaces
of 1- to 2-log10.
27,28
In addition, 3 clinical trials have been published in the
English literature that assessed the effectiveness of cooper-
coated surfaces to reduce HAIs (Table 1).23–31 Of these 3 trials,
2 reported that the intervention arm (ie, copper) had a
decreased incidence of HAIs,30,31 and 1 trial reported no
significant reduction in HAIs.29 Importantly, none of the trials
assessed the effectiveness of environmental cleaning and
disinfection using fluorescent dye or ATPase measurements,
and 1 did not assess compliance with hand hygiene.31
Although Salgado et al31 described their trial as a randomized
clinical trial, Muller et al22 described this study as “low-quality
evidence due to inappropriate randomization and lack of
blinding.” An additional clinical trial has been published in the
Spanish literature; it reported no differences in the frequency
of nosocomial infections as well as no difference in the rates of
ventilator-associated pneumonia, catheter-associated urinary
tract infections, or central line-associated bloodstream infec-
tions.32 However, this study was limited by its failure to
achieve its intended sample size.
The use of copper-coated surfaces to decrease contamina-
tion of hospital-room surfaces to decrease HAIs has several
potential advantages over current technologies, but it also has
several limitations, and several scientific questions remain
unanswered (Table 2). Copper-coated surfaces have demon-
strated the ability to inactivate many key pathogens associated
with HAIs. Multiple studies have demonstrated that copper-
coated surfaces can reduce the level of contamination on room
surfaces by 1- to 2-log10. Importantly, unlike the “no-touch”
methods that use UV devices or hydrogen peroxide systems
(which currently can only be used for terminal disinfection),
copper-coated surface provide continuous disinfection. To
date, clinical trials have reported only rare adverse reactions
related to contact with a copper-coated surface.
However, currently available studies still leave many ques-
tions regarding the routine use of copper-coated surfaces in
hospital rooms. First, it is unclear how many and which
surfaces must be coated to achieve a reduction in HAIs.
Second, the types of copper-coating that have been studied
vary, and widely accepted standard for such surfaces do not
exist. Third, only a limited number of clinical trials have been
published that have assessed whether copper-coated surfaces
reduce the incidence of HAIs, and among published studies,
copper-coated surfaces have not uniformly been shown to
reduce HAIs. Furthermore, the published studies have design
flaws including failure to use a randomized design and failure
to account for all possible confounding variables (eg, hand-
hygiene compliance and cleaning effectiveness). Fourth,
current studies investigating microbial reductions associated
table 1. Results of Selected Clinical Trials of Copper-Coated Versus Control Surfaces to Reduce Healthcare-Associated Infections





























HAI (RR, 0.22; P= .023)
C. difficile (RR, .017;
P= .48)
MDRO (RR, 0.32 P=NS)
Yes No Yes
Salgado, 2013 ICU RCT All HAI pathogens,
MRSA, VRE
6 items: bed rails,
overbed table, IV
poles, arms visitor’s






HAI (RR, 0.42; P= .013)
MRSA or VRE
colonization
(RR, 0.36; P= .063)
No No Not
mentioned
NOTE. Cu, copper; HH, hand hygiene; EVS, environmental service; HAI, healthcare-associated; RR, relative risk; PICU, pediatric intensive care
unit; PIMCU, pediatric intermediate care unit; IV, intravenous; NS, not significant; MRSA, methicillin-resistant Staphylococcus aureus; VRE,
vancomycin-resistant Enterococcus spp; RCT, randomized clinical trial.
table 2. Advantages and Limitations in the Use of Copper as a Self-Disinfecting Surface in Hospital Rooms
Potential Advantages
∙ Demonstrated in vitro microbicidal effectiveness including sporicidal activity
∙ Demonstrated ability to reduce the level and frequency of bacterial contamination on copper-coated surfaces in patient rooms
∙ Adverse reactions to contact with copper-coated surfaces very uncommon
∙ Provides continuous disinfection of copper-coated surfaces (ie, unlike ultraviolet devices and hydrogen peroxide systems, its use is not
limited to terminal disinfection)
Potential Limitations and Deficiencies in the Scientific Literature
∙ Unclear how many and which surfaces must be coated
∙ Likelihood and frequency of development of reduced susceptibility to copper in healthcare-associated pathogens not well studied
∙ Only limited data that use of copper-coated surfaces will reduce healthcare-associated infections. Further, existing clinical trials have
potential design flaws (ie, none assessed environmental cleaning effectiveness)
∙ Available in vitro studies and clinical trials have evaluated a variety of types of copper coatings (ie, no agreement best method to use)
∙ Cost of purchasing copper-coated surfaces not described in the scientific literature
∙ Durability of copper-coated surfaces in patient rooms poorly described
∙ Cost-effectiveness of using copper-coated surfaces to reduce healthcare-associated pathogens not available
with copper-coated surfaces or clinical outcomes (ie, reduc-
tion of HAIs) have rarely assessed whether residual microbes
had intrinsic or acquired resistance to copper. Survival on
copper surfaces has been described and appears to be the
consequence of endospore formation, survival on patches of
dirt, or a special ability to endure a dry metallic copper sur-
face.23 The frequency and importance of reduced susceptibility
to copper among healthcare-associated pathogens remains
poorly defined but likely will not be clinically significant. Fifth,
the cost of purchasing, installing, and maintaining copper-
coated surfaces has not been delineated. Sixth, the durability of
copper-coated surfaces has been poorly described. Finally, no
cost-effective analysis of the use of copper-coated surfaces has
been published.
In conclusion, the use of copper-coated surfaces to provide
continuous room disinfection is promising, but additional
carefully designed and appropriately powered studies are
required before this technology should be routinely adopted to
prevent HAIs.
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